In accordance with IFRS 8, the non-current assets reported below exclude financial instruments, deferred tax assets, and pre-funded pension obligations.
| 2017 | ||||||||||||||||||||||||
| (€ million) | Total Sanofi | Europe | of which France |
North America |
of which United States |
Other countries |
||||||||||||||||||
| Net sales | 35,055 | 9,525 | 2,330 | 12,460 | 11,855 | 13,070 | ||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||||||
|
∎ property, plant and equipment |
9,579 | 5,969 | 3,180 | 2,560 | 2,142 | 1,050 | ||||||||||||||||||
|
∎ goodwill |
40,264 | |||||||||||||||||||||||
|
∎ other intangible assets |
13,080 | 6,171 | 5,210 | 1,699 | ||||||||||||||||||||
| 2016 | ||||||||||||||||||||||||
| (€ million) | Total Sanofi | Europe | of which France |
North America |
of which United States |
Other countries |
||||||||||||||||||
| Net sales | 33,821 | 8,679 | 2,206 | 12,963 | 12,391 | 12,179 | ||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||||||
|
∎ property, plant and equipment |
10,019 | 6,068 | 3,413 | 2,850 | 2,447 | 1,101 | ||||||||||||||||||
|
∎ goodwill |
40,287 | |||||||||||||||||||||||
|
∎ other intangible assets |
10,879 | 3,612 | 5,430 | 1,837 | ||||||||||||||||||||
| 2015 | ||||||||||||||||||||||||
| (€ million) | Total Sanofi | Europe | of which France |
North America |
of which United States |
Other countries |
||||||||||||||||||
| Net sales(a) | 34,060 | 9,861 | 2,248 | 12,369 | 11,764 | 11,830 | ||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||||||
|
∎ property, plant and equipment |
9,943 | 5,956 | 3,480 | 2,879 | 2,498 | 1,108 | ||||||||||||||||||
|
∎ goodwill |
39,557 | |||||||||||||||||||||||
|
∎ other intangible assets |
12,026 | 3,719 | 5,980 | 2,327 | ||||||||||||||||||||
| (a) |
Following a change in accounting presentation in 2016, VaxServe sales of non-Sanofi products are included in Other revenues. The presentation of 2015 Net sales and Other revenues has been amended accordingly (see Note B.13.). |